Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
about
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesAdoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.Chemoimmunotherapy.Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy.Chemotherapy and tumor immunity: an unexpected collaborationGraft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series.Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy.Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.Tumor vaccines for breast cancerElectroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma.Unravelling the complexity of cancer-immune system interplay.Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.Chemoimmunotherapy: reengineering tumor immunity.Blessing or curse? Proteomics in granzyme research.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages.Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model.Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas.Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study.Eradication of established renal cell carcinoma by a combination of 5-fluorouracil and anti-4-1BB monoclonal antibody in mice.An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma.
P2860
Q26863779-003DE66C-35D6-4909-8AE2-3D15FCB08234Q33713511-8DDB5B59-E8D6-45D7-93CE-18F0B4AC149DQ34058792-41F194AE-2467-4C94-9BC8-1F387145246EQ34774821-21C75EC8-140A-43A0-A1B6-2826B068B53BQ34909777-A7652201-9356-4324-A64C-157964828578Q34983740-F64FC947-823E-4318-9CB4-FC44751CE99CQ35053993-DE48001B-8112-4CB2-8D11-9EB7D741E540Q35889643-4E16F621-7EFF-4DAE-ABCF-B1F1D505BE04Q36204803-FDF97C64-E587-48A3-AF03-A39746EE0341Q36694876-3699FCEB-92C2-4839-BA15-D02D4BACF2C9Q37299843-0B56A94A-3563-4855-A2E8-6E529733D95FQ37473603-5103729B-7415-479D-88A2-3EE6433A7E48Q37765590-0EEACEBA-1211-4C12-89BF-659039E38157Q37969356-37664FC2-6EB3-4B69-B59E-5BA1977A79E2Q38079749-179F4942-5281-4D71-B007-73C60E676E8EQ38200060-87E5253D-842E-4748-9EC3-448D290A3762Q38223419-1D4C1D48-1D1C-4721-9CFF-22092D645315Q38447992-2406AFA6-DDF8-43B8-BAD9-80112C790AE6Q39637537-A73A5E39-2AE3-4F42-A73D-F995D9AE8C59Q39650152-78B9F8AB-B650-465D-B4F0-509EAFAE27A2Q39848254-7012B8B3-33F2-45C8-A84F-9C8B9352F5A6Q42378707-F35638D2-6115-47F2-96EE-301BD01BC6BFQ46686977-A7709827-56C4-45B1-9325-C527B5DE628FQ48132700-4945F8B0-7406-401D-B8FE-80AF022F6D52
P2860
Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treatment of melanoma with 5-f ...... me- and Fas-mediated pathways.
@en
type
label
Treatment of melanoma with 5-f ...... me- and Fas-mediated pathways.
@en
prefLabel
Treatment of melanoma with 5-f ...... me- and Fas-mediated pathways.
@en
P1476
Treatment of melanoma with 5-f ...... me- and Fas-mediated pathways.
@en
P2093
Frank G Haluska
Sixun Yang
P304
P356
10.4049/JIMMUNOL.172.7.4599
P407
P577
2004-04-01T00:00:00Z